NMC
SGMT icon

NEA Management Company’s Sagimet Biosciences SGMT Stock Holding History

NEA Management Company’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000,275
Closed -$9M – 41
2024
Q4 		$9M Hold
2,000,275
– – 0.51% 28
2024
Q3 		$5.54M Hold
2,000,275
– – 0.3% 32
2024
Q2 		$6.84M Hold
2,000,275
– – 0.51% 30
2024
Q1 		$10.8M Sell
2,000,275
-1,850,000
-48% -$13.3M 0.67% 28
2023
Q4 		$18.8M Hold
3,850,275
– – 1.25% 15
2023
Q3 		$27.1M Buy
+3,850,275
New +$51.3M 2.09% 15

Other funds holding SGMT

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

NEA Management Company's SGMT Position: Q1 2025 in Review

NEA Management Company sold out of Sagimet Biosciences (SGMT) in Q1 2025, closing a stake of 2,000,275 shares — an estimated $9M sold.

NEA Management Company first reported a position in SGMT in Q3 2023 and held it in 6 quarters. The position peaked at $27.1M in Q3 2023. 70 funds tracked by Wall St. Rank hold SGMT as of Q1 2025.

  • NEA Management Company reported no remaining Sagimet Biosciences position as of Q1 2025 after selling out during the quarter.
  • NEA Management Company sold 2,000,275 Sagimet Biosciences shares in Q1 2025, an estimated $9M.
  • NEA Management Company first reported a position in Sagimet Biosciences in Q3 2023 and held it in 6 quarters.
  • NEA Management Company's Sagimet Biosciences position peaked at $27.1M in Q3 2023.
  • 70 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2025.

Based on NEA Management Company's 13F filing for Q1 2025, filed 14 May 2025.